CMV and EBV Reactivation after Allogeneic Transplantation

被引：1
|
作者：
Butler, Andrew [1 ]
Thurston, Andrew [2 ]
机构：
[1] Canterbury Hlth Labs, Christchurch, New Zealand
[2] Christchurch Hosp, Christchurch, New Zealand
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2015年 / 21卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2014.11.381
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
334
引用
收藏
页码：S244 / S244
页数：1
相关论文
共 50 条
  • [21] Prevention of cytomegalovirus (CMV) reactivation by standard dose valacyclovir (VACV) after allogeneic bone marrow transplantation
    Mori, T
    Shimizu, T
    Aisa, Y
    Ikeda, Y
    Okamoto, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 30 - 30
  • [22] CMV REINFECTION REACTIVATION AFTER LIVER-TRANSPLANTATION
    ARNOLD, JC
    OGRADY, JG
    OTTO, G
    KOMMERELL, B
    ALEXANDER, GJM
    WILLIAMS, R
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (05) : 2632 - 2633
  • [23] CMV and EBV reactivation in autologous haemopoietic stem cell transplantation for severe multiple sclerosis
    Saccardi, R.
    Donnini, I.
    Repice, A.
    Maggi, P.
    Di Gioia, M.
    Andreoli, E.
    Bosi, A.
    Guidi, S.
    Gozzini, A.
    Massacesi, L.
    Amato, M. P.
    Nozzoli, C.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S378 - S379
  • [24] Influence of Donor Cytomegalovirus (CMV) Status on Severity of Viral Reactivation after Allogeneic Stem Cell Transplantation in CMV-Seropositive Recipients
    Pietersma, Floor L.
    van Dorp, Suzanne
    Minnema, Monique C.
    Kuball, Jurgen
    Meijer, Ellen
    Schuurman, Rob
    van Baarle, Debbie
    CLINICAL INFECTIOUS DISEASES, 2011, 52 (07) : E144 - E148
  • [25] NORMALISED EBV QUANTITY IN PATIENTS AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION - BENIGN REACTIVATION, LOCALISED AND GENERALISED EBV LYMPHOPROLIFERATIVE DISEASE
    Hubacek, P.
    Mejstrikova, E.
    Markova, M.
    Kouba, M.
    Kabickova, E.
    Zajac, M.
    Hornofova, L.
    Keslova, P.
    Sedlacek, P.
    Cetkovsky, P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S295 - S295
  • [26] Normalised EBV quantity in patients after allogeneic haematopoietic stem cell transplantation - Benign reactivation, localised and generalised EBV lymphoproliferative disease
    Hubacek, P.
    Hrdlickova, A.
    Mejstrikova, E.
    Valkova, V.
    Kabickova, E.
    Capkova, L.
    Keslova, P.
    Formankova, R.
    Markova, M.
    Cetkovsky, P.
    Sedlacek, P.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S45 - S45
  • [27] Differences in Reconstitution of T Cell Immunity to CMV, VZV and EBV After Allogeneic Hematopoietic Cell Transplantation (HCT)
    Khan, Faisal
    Sy, Sarah
    Liu, Stephanie
    Zhou, Feng
    Liu, Yiping
    Ugarte-Torres, Alejandra
    Storek, Jan
    CLINICAL IMMUNOLOGY, 2009, 131 : S65 - S65
  • [28] CMV, BKV, HHV-6B, AdV, and EBV Kinetics after Allogeneic Hematopoietic Cell Transplantation
    Hill, Joshua A.
    Mayer, Bryan
    Xie, Hu
    Leisenring, Wendy M.
    Huang, Meei-Li
    -Ayers, Terry L. Stevens
    Milano, Filippo
    Delaney, Colleen
    Jerome, Keith R.
    Zerr, Danielle
    Nichols, Garrett
    Boeckh, Michael J.
    Schiffer, Joshua T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S165 - S166
  • [29] Risk pattern of EBV-reactivation following allogeneic stem cell transplantation
    Bauhardt, A.
    Dammann, E.
    Stadler, M.
    Eder, M.
    Krauter, J.
    Ganser, A.
    Buchholz, S.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S221 - S221
  • [30] Risk for CMV Reactivation in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Qayed, Muna
    Khurana, Monica
    Hilinski, Joseph
    Gillespie, Scott
    McCracken, Courtney
    Applegate, Kristy
    Chiang, Kuang-Yueh
    Horan, John
    PEDIATRIC BLOOD & CANCER, 2015, 62 (02) : 364 - 366
12345